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Abstract Regulators of G-protein signaling (RGS) are
GTPase-activating proteins (GAP) for activated GK subunits.
We found that mouse RGS16, when expressed in HEK293T
cells, is phosphorylated constitutively at serine 194 based on in
vivo orthophosphate labeling experiments, while serine 53 is
phosphorylated in a ligand-dependent manner upon stimulation
by epinephrine in cells expressing the K2A adrenergic receptor.
Phosphorylation on both sites impairs its GAP activity and
subsequent attenuation on heterotrimeric G-protein-stimulated
extracellular signal-regulated protein kinase activity. This is the
first report of RGS functional downregulation by phosphoryla-
tion via a G-protein-coupled receptor. ß 2001 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Signal transduction pathways originating from G-protein-
coupled receptors (GPCR) are among the most important and
widespread signaling cascades in mammalian systems. They
mediate crucial body functions ranging from light, odor,
and pain perception, blood pressure regulation, in£ammatory
response, neurotransmission, etc. A family of regulators of G-
protein signaling (RGS) have been discovered [1^3] which
bind to activated GK subunits to accelerate their GTP hydro-
lysis rate, thereby terminating signals initiated from ligand-
occupied GPCR, and acting as GTPase-activating proteins
(GAP).
There are currently more than 20 mammalian RGS proteins
being identi¢ed based on a conserved domain of about 120
amino acid residues known as the RGS box [3]. Although
these RGS proteins exhibit binding promiscuity for GK sub-
units as assayed in vitro, increasing evidence has indicated
that individual RGS members have biological speci¢city.
For example, RGS16 preferentially inhibited platelet-activat-
ing factor stimulation of the mitogen-activated protein kinase
(MAPK) p38 via Gq=11K subunits, but not platelet-activating
factor initiated extracellular signal-regulated protein kinase
(ERK) [4]. The speci¢city of RGS to G-protein interaction
is also shown by a substantial enhancement of GTPase activ-
ity of Gi2K over Go1K by RGS4 upon K2A adrenergic receptor
stimulation [5]. Furthermore, it is likely that the great diver-
sity of sequences beyond the RGS box may confer distinct
properties to the various RGS proteins. The G-protein Q sub-
unit-like domain for instance, is found in RGS6, 7, 9, and 11,
which enables these RGS proteins to speci¢cally bind to the
GL5 subunit [6,7]. The pleckstrin homology domain, which
binds phosphoinositides, is found in p115-RhoGEF and
PDZ-RhoGEF, two RGS proteins that preferentially interact
with G12K and G13K subunits [8]. Post-translational modi¢ca-
tions of RGS proteins also play roles in modulating the ac-
tivity of RGS proteins. Palmitoylation of RGSZ1, RGS4, and
RGS10 regulated their GAP activity [9], especially if it in-
volved cysteine residues in the RGS box [10]. In addition,
palmitoylation of N-terminal cysteine residues may be essen-
tial for membrane localization of certain RGS proteins [11].
Recently, there are reports that RGS proteins are phospho-
proteins. In the yeast Saccharomyces cerevisiae, the RGS pro-
tein Sst2p is phosphorylated by MAPK in response to pher-
omone stimulation [12]. The phosphorylation appears to slow
the rate of Sst2p degradation. A mammalian RGS protein,
GK-interacting protein (GAIP), was also observed to be phos-
phorylated by the MAPK ERK2 [13]. In vitro phosphoryla-
tion of GAIP enhances its GTPase activity, and is necessary
for stimulating the lysosomal autophagic pathway in human
colon cancer HT-29 cells.
In view that post-translational modi¢cations may a¡ect the
stability and activity of RGS proteins, we set out to study
how such modi¢cations might a¡ect RGS16, which we had
previously cloned from a mouse pituitary library [14,15].
RGS16 is known to be palmitoylated at its amino-terminal
cysteine residues 2 and 12 based on the observation of Druey
et al. [16], and it has an N-terminal amphipathic K-helical
domain critical for its plasma membrane localization [17].
However, no study has been conducted on the phosphoryla-
tion of RGS16 and its biological e¡ect. We hereby show that
the RGS16 protein is phosphorylated both constitutively and
in a ligand-dependent manner on di¡erent serine residues.
Phosphorylation of RGS16 on both sites decreases its GAP
activity towards the GK subunit, and impairs its potency to
inhibit ligand-stimulated MAPK activity.
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2. Materials and methods
2.1. Construction of plasmids
The plasmids for pCMV5-RGS16 and FLAG-tagged pCMV5-
ERK2 were constructed as described previously [4,14]. A FLAG tag
was incorporated at the C-terminus of RGS16 in the pCMV5 vector
before the stop codon by polymerase chain reaction. Serine to alanine
or glutamate mutants of RGS16 were generated using the Transform-
er1 Site-directed Mutagenesis Kit (Clontech) and correct identities
were con¢rmed by sequencing. The K2A adrenergic receptor was a
kind gift from Dr. G. Milligan (University of Glasgow, UK). (His)6-
tagged GoK in the pQE30 plasmid (Qiagen) was generated as de-
scribed previously [23]. The plasmids for (His)6-tagged wild-type, ala-
nine, and glutamate mutants of RGS16 were constructed by fusing the
respective RGS16 cDNAs to the C-terminally (His)6-tagged pQE30
vector.
2.2. Cell culture, transfection, and immunoprecipitation
Human embryonic kidney 293T (HEK293T) cells were maintained
in RPMI 1640 medium as previously described [4] and transfected
using DOSPER (Boehringer Mannheim) according to the manufac-
turer’s instructions. Empty vector pCMV5 was used to normalize the
amount of DNA in each transfection. Cell lysis and immunoprecipi-
tation of FLAG-tagged proteins using M2 (anti-FLAG) beads (Sig-
ma) were performed essentially as described previously [16].
2.3. In vivo orthophosphate labeling
In vivo orthophosphate labeling was carried out as described by
Ploegh [18]. Brie£y, HEK293T cells were plated onto 35 mm dishes
for transfection with the desired plasmids. At 36 h post-transfection,
the cells were rinsed with, and incubated for 3 h in, phosphate-free
MEM medium (Sigma) containing 1% dialyzed fetal bovine serum
(FBS, Gibco BRL, Life Technologies). This was followed by another
rinse and an additional 1 h incubation in the same medium before
changing to 0.5 ml of phosphate-free medium containing 5% dialyzed
FBS for 30 min. [32P]-labeled orthophosphate [32Pi] was then added to
each dish to give a ¢nal concentration of 1.2 mCi/ml, for a duration of
4^6 h. Cells were stimulated with or without epinephrine (100 WM) for
30 min and then washed once with ice-cold PBS before lysing in 600
Wl of lysate bu¡er. Following immunoprecipitation of the [32Pi]-la-
beled FLAG-tagged RGS16 protein, the immunoprecipitates were
boiled in 60 Wl of Laemmli sample bu¡er and separated on a 12%
SDS^PAGE gel. Resolved proteins were then transferred onto a poly-
vinylidene £uoride (PVDF) membrane for phosphoamino acid map-
ping or a nitrocellulose membrane for cyanogen bromide cleavage
analysis.
2.4. Phosphoamino acid mapping
Phosphoamino acid analysis was performed using two-dimensional
thin-layer chromatography (2D-TLC). Brie£y, the bands on the
PVDF membrane which corresponded to the [32Pi]-labeled RGS16
protein were excised and cut into ¢ne pieces before incubating in
200 Wl of 5.7 N HCl at 110‡C for 1 h. The supernatant containing
the acid-hydrolyzed protein was transferred to a new tube and dried
for 2 h in a speed-vacuum dryer. The resultant pellet was resuspended
in 9 Wl of 1D bu¡er (pH 1.9) containing 2.25% formic acid and 7.8%
glacial acetic acid, before mixing with 2 Wl of phosphoamino acid
standards (Sigma). The sample was spotted onto a cellulose-coated
glass plate for separation in a TLC electrophoresis system. The ¢rst
dimension electrophoresis was performed at 1.5 kV, 20 mA current
for 22 min in 1D bu¡er; electrophoresis of the second dimension was
performed at 1.4 kV for 18 min in 2D bu¡er (pH 3.9) containing 5%
glacial acetic acid and 0.5% pyridine. The sample plate was air-dried
for 30 min and sprayed with 0.25% ninhydrin, followed by incubation
in an oven set at 65‡C for 10^15 min until the standard amino acid
appeared. Autoradiography of the plate revealed phosphorylated ami-
no acids.
2.5. Cyanogen bromide cleavage
[32Pi]-labeled proteins transferred onto the nitrocellulose membrane
were digested in 200 Wl of cyanogen bromide (100 mg/ml in 70%
formic acid) in the dark at room temperature for 90 min. The digested
proteins in the supernatant were dried in a speed-vac for 1 h, and
resuspended in 500 Wl of H2O, followed by evaporation for another
2 h. The ¢nal sample was dissolved in 30 Wl of sample bu¡er, boiled
for 5 min, and then separated on a small-pore 16.5% T, 6% C tricine^
SDS^PAGE gel with 6 M urea as described by Scha«gger et al. [19].
2.6. GAP activity assays
The GAP activity of individual RGS16 proteins was carried out
based on a single-step GTP hydrolysis according to previous descrip-
tion [23]. Speci¢cally, the GoK protein and individual RGS16 proteins
were generated and puri¢ed from bacteria as N-terminal (His)6 fusion
proteins. 0.25 WM of GoK protein was incubated with 1 WM
[Q-32P]GTP in the absence of Mg2 at 30‡C for 30 min, and then
transferred to an ice bath for 5 min. The hydrolysis of GTP to
GDP was initiated by incubating the GTP-preloaded GoK mixture
with 2 WM RGS16 protein and 10 mM Mg2 at 8‡C. The GAP
activity was determined by subtracting remaining [32P] counts at the
indicated time-point from counts on ¢lters at zero time-point.
2.7. Phospho-ERK blotting
RGS16 wild-type, alanine, and glutamate mutants of S53 and S194
(0.7 Wg each) were expressed in HEK293T cells plated on 60 mm
dishes, together with the K2A adrenergic receptor (0.5 Wg) and
FLAG-tagged ERK2 (0.5 Wg). At 30 h after transfection, the cells
were serum-starved overnight before stimulation with epinephrine
(100 WM) for 15 min. ERK2 kinase was immunoprecipitated and
separated on a 10% SDS^PAGE gel before immobilization onto
PVDF blotting membrane. The level of ERK phosphorylation was
detected by immunoblotting with phospho-p44/p42 MAPK (Thr202/
Tyr204) E10 monoclonal antibody (Cell Signaling Technology) accord-
ing to the manufacturer’s instructions. The amount of kinase loaded
was further determined by probing with anti-ERK polyclonal antibody
(Santa Cruz) after stripping the same membrane with Restore1 West-
ern Blot Stripping Bu¡er (Pierce). The expression levels of RGS16
proteins in cells were examined by immunoblotting the cell lysates
with anti-RGS16 polyclonal antibody as previously described [4].
3. Results
3.1. RGS16 is constitutively phosphorylated at serine 194
We found that RGS16 is a phosphoprotein based on in vivo
orthophosphate labeling experiments (Fig. 1A). These were
performed by transfecting HEK293T cells with the C-terminal
FLAG-tagged mouse RGS16 (the N-terminal tagging attenu-
ated RGS16 function, data not shown). After 36 h, free phos-
phate in the medium was removed by rinsing and incubating
the cells with phosphate-free medium. After 5^6 h, [32P]-la-
beled orthophosphate was added to the cells for at least 4 h.
The cells were then lysed, and the FLAG-RGS16 protein was
immunoprecipitated with M2 anti-FLAG beads. Autoradiog-
raphy of the SDS^PAGE gel of the immunoprecipitated pro-
teins showed a distinct band corresponding to FLAG-tagged
RGS16 at around 25 kDa (Fig. 1A), which is not present in
proteins immunoprecipitated from vector (pCMV5)-trans-
fected HEK293T cells. A polyclonal anti-RGS16 antibody
further con¢rmed the 25 kDa [32Pi]-labeled band as the full-
length RGS16. The antibody also detected a break-down frag-
ment of RGS16, which is not [32Pi]-labeled.
Analysis of the phosphorylated protein by phosphoamino
acid mapping indicated that serine residues of RGS16 are
phosphorylated (Fig. 1B). A preliminary assessment of the
site of phosphorylation was then carried out by digesting
the [32Pi]-labeled RGS16 with cyanogen bromide. As cyano-
gen bromide cleaves a polypeptide at the C-terminus of me-
thionines, it is expected to digest FLAG-RGS16 at methionine
1 and 162 to give a 18.5 kDa N-terminal fragment and a 5.4
kDa C-terminal fragment (including the FLAG tag sequence).
Subsequently, the C-terminal fragment (residues 163^201) was
found to be [32Pi]-labeled (Fig. 1C).
Serine residues in the C-terminal fragment were individually
mutated to alanine and subjected to in vivo orthophosphate
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labeling. The alanine mutant of serine 194 clearly prevented
the incorporation of [32Pi] onto the RGS protein (Fig. 1D).
The dramatic loss of constitutive phosphorylation on the
RGS16 (S194A) mutant precludes the possibility of phosphor-
ylation at other serine residues on the C-terminal.
3.2. Stimulation of K2A adrenergic receptor expressing cells
with epinephrine induces phosphorylation at serine 53
Stimulation of GPCRs frequently results in the activation
of various kinases including protein kinase A, protein kinase
C, G-protein-regulated kinases and the MAPK. These kinases
mediate the responses of GPCR activation or feedback to
regulate the intensity and duration of signaling. As RGS pro-
teins are negative regulators of G-protein signaling, we are
keen to explore whether RGS proteins may themselves also
be regulated in a ligand-dependent manner.
The K2A adrenergic receptor is widely distributed in mam-
malian cells [20] and is promiscuous in activating various GK
subunits [21]. It is also known to activate the MAPK path-
ways, especially the ERK. Stimulation by epinephrine (100
WM) for 30 min in HEK293T cells expressing the K2A adren-
ergic receptor resulted in [32Pi]-labeling of the RGS16 (S194A)
mutant protein (Fig. 2A). This e¡ect was not apparent in
wild-type RGS16, due to the constitutive phosphorylation at
serine 194. Phosphoamino acid mapping again showed that
the serine residue, but not tyrosine or threonine, was phos-
phorylated (Fig. 2B). Cyanogen bromide cleavage showed
that the N-terminal fragment (2^162) was phosphorylated
upon ligand stimulation (result not shown). Various serine
to alanine mutants were constructed and subjected to in
vivo labeling assays. After an extensive search, mutation of
serine 53 to alanine was found to abolish epinephrine-stimu-
lated [32Pi] incorporation onto the RGS16 (S194A) protein
(Fig. 2C).
Fig. 1. RGS16 is a phosphoprotein when expressed in HEK293T cells. A: The FLAG-tagged RGS16 was transiently expressed in HEK293T
cells, in vivo labeled with [32P]orthophosphate, immunoprecipitated with anti-FLAG antibody, and was resolved on a 12% SDS^PAGE gel be-
fore transferring to the PVDF membrane. Top panel is an autoradiograph showing the incorporation of [32Pi] on RGS16 (right lane), but not
on vector-transfected cells (left lane). Bottom panel is a blot of the same membrane probed with anti-RGS16 antibody. B: Phosphoamino acid
mapping of the [32Pi]RGS16 band in (A) using 2D-TLC electrophoresis indicated that serine residues were phosphorylated. The relative posi-
tions of the ninhydrin-stained amino acid standards are indicated within dash-lined circles. C: Cyanogen bromide (CNBr) cleavage of
[32Pi]RGS16 protein showed that only the shorter 5.4 kDa C-terminal fragment was [32Pi]-labeled (right lane). D: FLAG-tagged alanine mutant
constructs of RGS16 were expressed and subjected to in vivo orthophosphate labeling as in (A). Top panel is an autoradiograph of the [32Pi]-
labeled proteins. Bottom panel shows Western blotting of the same membrane with anti-RGS16 antibody, indicating similar expression of the
various alanine mutants.
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3.3. Double-glutamate mutants of serine 53 and serine 194
diminished RGS16 GAP activity on GoK
As previously shown, RGS16 binds to the transition state
of GK subunits and acts as a GAP to enhance the intrinsic
GTPase activity of GoK [23]. We therefore examined the GAP
activities of these mutants. RGS16 mutants at serine 53 and
serine 194, which mimic loss (serine to alanine) or gain (serine
to glutamate) of phosphorylation, were constructed and as-
sayed for their interactions with G proteins. These RGS16
mutant proteins were generated and expressed in bacteria
cells, and ¢rst subjected to G-protein binding assays as pre-
viously described [14]. All mutants tested retained similar
Fig. 2. RGS16 is phosphorylated upon ligand stimulation. A: FLAG-tagged wild-type (WT) RGS16 or FLAG-tagged mutant RGS16 (S194A)
was co-expressed with K2A adrenergic receptor in HEK293T cells (using 1 Wg of RGS16 cDNA +0.5 Wg K2A adrenergic receptor cDNA) and
subjected to in vivo [32P]orthophosphate labeling. Epinephrine (100 WM) was added 30 min before harvest. The RGS16 proteins were immuno-
precipitated and resolved on SDS^PAGE gel as in Fig. 1A. Top panel shows the ligand-dependent incorporation of [32Pi] into RGS16 proteins;
bottom panel shows anti-RGS16 probe analysis of the same membrane, indicating similar expression of the proteins. B: Phosphoamino acid
analysis was performed on the epinephrine-stimulated [32Pi]-labeled RGS16 (S194A) as described in (A). The relative positions of the ninhy-
drin-stained amino acid standards are indicated within dash-lined circles. C: Various FLAG-tagged alanine mutant constructs of RGS16 were
expressed and subjected to in vivo orthophosphate labeling under the stimulation of epinephrine as described in (A). Top panel is an autoradio-
graph of the [32Pi]-labeled proteins. Bottom panel shows Western blotting of the same membrane with anti-RGS16 antibody, indicating similar
expression of the alanine mutants.
Fig. 3. GAP activity of various RGS16 proteins. The single-turnover assay was carried out to assess the GAP activity of each RGS16 protein.
The time curves of GTP hydrolysis for GoK (0.25 WM) were obtained by preloading GoK with [Q-32P]GTP at 30‡C, and then incubating with
the reaction bu¡er (w/o RGS) or with 2 WM of wild-type RGS16 (WT), or the same amount of RGS16 mutant proteins at 8‡C. The GAP ac-
tivities on GoK of Ser-53 mutants (S53A, S53E), Ser-194 mutants (S194A, S194E), and Ser-53/Ser-194 mutants (S53A/S194A, S53E/S194E), to-
gether with the WT RGS16, are shown in panels A, B, and C, respectively.
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binding capacity towards in vitro generated [35S]-labeled GK
subunits (GoK, Gi2K, and Gi3K ; data not shown), indicating
that these proteins are properly folded. Single-turnover
GTPase activity of GoK was used to determine the GAP ac-
tivity of individual RGS16 mutants at 8‡C. In the absence of
RGS protein, GoK displayed an intrinsic GTPase activity to
hydrolyze bound [Q-32P]GTP to [32Pi] and GDP (Fig. 3). In
the presence of excess amounts (eight-fold) of recombinant
RGS16 protein, maximal [Pi] release was observed in a
much shorter time (less than 8 s). Single mutants of serine
53 or serine 194 (S53A, S53E, S194A, and S194E) retained
their full capacity as wild-type RGS16 to stimulate GTP hy-
drolysis by GoK (Fig. 3A,B). Surprisingly, only the double-
glutamate mutant (S53E/S194E), but not the double-alanine
mutant (S53A/S194A), exhibited a signi¢cantly reduced GAP
function (Fig. 3C). This suggests that the phosphorylation of
RGS16 on both serine residues diminished its capacity as a
GAP for GK subunit.
3.4. Epinephrine-stimulated phosphorylation of RGS16
attenuates its ability to inhibit MAPK activation
RGS16 was previously shown to interact with GiK, GoK,
and GqK proteins [4,14] and attenuate GqK-mediated p38-
MAPK activation by the platelet-activating factor [4]. We
therefore further studied the ability of RGS16 to inhibit
ERK2 activation by the K2A adrenergic receptor. Time-
course determination of ERK2 activity was performed by
stimulating the cells with epinephrine at various time points
(5, 15, and 30 min), followed by cell lysis and immobilization
of FLAG-tagged ERK2 onto M2 beads, and Western blotting
with speci¢c phospho-p44/p42 MAPK antibody. Upon stim-
ulation, the level of phospho-ERK2 protein increased rapidly
and reached a maximum within 5 min; this high activity was
maintained until 30 min (data not shown). Co-expression of
the RGS16 protein attenuated epinephrine-stimulated ERK2
activation at all the time points tested, with the most obvious
e¡ect at 15 min. We therefore used this time point to test the
various RGS16 proteins.
From Fig. 4, we can see that the level of phospho-ERK2
was strongly elevated upon epinephrine stimulation of the
cells expressing the K2A adrenergic receptor (Fig. 4, vector
control). Expressing wild-type RGS16 in these cells signi¢-
cantly reduced the magnitude of ERK2 phosphorylation
(Fig. 4, WT). In addition, both the single-alanine mutants
(S53A, or S194A) and the double-alanine mutant (S53A/
S194A) did not exhibit any di¡erence from wild-type
RGS16 in attenuating epinephrine-stimulated ERK phosphor-
ylation. Similar to the alanine mutants, alteration of serine
194 to glutamate (S194E) also had little e¡ect. In contrast,
the single-glutamate mutant (S53E) and double-glutamate
mutant (S53E/S194E) partially lost their ability to inhibit
ERK2 phosphorylation by 50% (Fig. 4). As serine 194 is
constitutively phosphorylated in mammalian cells (as shown
in Fig. 1), it was presumed that the single-glutamate mutant
(S53E), when expressed in 293T cells, should mimic the e¡ect
of the double-glutamate mutant (S53E/S194E). Although we
failed to notice a reduction in GAP activity by the single-
glutamate mutant (S53E), this is likely due to the absence of
constitutive phosphorylation on serine 194 for bacteria-ex-
pressed proteins. Moreover, the double-glutamate mutant
(S53E/S194E), which mimics phosphorylation on both serine
residues, consistently reduced the GAP and MAPK attenua-
tion capacity of RGS16. Therefore, it appears that in mam-
malian cells, epinephrine stimulation can regulate the function
of RGS16 via phosphorylation.
4. Discussion
Our current study shows that serine residues of RGS16 are
phosphorylated constitutively (S194) and in a ligand-depen-
dent manner (S53). Serine 194 is unique to mouse RGS16 and
is not found in the human homolog, while serine 53 is com-
Fig. 4. Inhibitory e¡ect of RGS mutants on the epinephrine-stimulated ERK2 activation. RGS16 wild-type, alanine, or glutamate mutants of
Ser-53 and Ser-194 were expressed in HEK293T cells, together with the K2A adrenergic receptor and FLAG-tagged ERK2. The cells were se-
rum-starved overnight before stimulation with epinephrine for 15 min. Kinase activity of each FLAG-tagged immunoprecipitate was detected
by immunoblotting with anti phospho-ERK antibody. The histogram shows the fold activation of ERK2 for the various RGS16 constructs in
the absence (3) or presence (+) of epinephrine stimulation, based on the phosphorylation of ERK2 protein ([Pi]-ERK2, indicated on the right),
normalized to the amount of precipitated FLAG-ERK2 in each sample (ERK2, indicated on the right). The expression of di¡erent RGS16 mu-
tants (bottom panel) was noted to be similar. WT: wild-type.
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mon to RGS16 from both species and is located at the ex-
treme N-terminus of the RGS domain, within the ¢rst K-helix.
Our results indicate that the double-glutamate mutant (S53E/
S194E) signi¢cantly reduced the GAP capacity of RGS16
protein, and consistently exhibited diminished ability to atten-
uate the K2A adrenergic receptor-stimulated ERK activation.
As epinephrine-stimulated phosphorylation of RGS16 on ser-
ine 53 was observed at least after 15 min (data not shown), it
appears that a sustained stimulation of the K2A adrenergic
receptor was needed to downregulate RGS16 activity. This
is a novel observation of the e¡ect of sustained stimulation
of a GPCR on the RGS16 protein.
Ligand-dependent phosphorylation of RGS proteins was
previously shown for the yeast RGS member (Sst2) on serine
539 within a consensus MAPK phosphorylation sequence [12].
Phosphorylation of Sst2p by the MAPK Fus3p does not a¡ect
desensitization of yeast pheromone response, but instead de-
creases the rate of Sst2 degradation, due to a feedback regu-
lation of the RGS protein in response to pheromone stimula-
tion. Among the mammalian RGS proteins, RGS7 has been
shown to be phosphorylated by the stress-activated protein
kinase p38 upon tumor necrosis factor-K treatment, which
prevents the proteasome-dependent degradation of RGS7
[22]. In our current study on RGS16, the phosphorylation
sites at S53 and S194 bear little resemblance to the consensus
MAPK phosphorylation sequence (PXSP), which is in accor-
dance with the observation that addition of MAPK inhibitors
SB203580 or PD98059 failed to block the constitutive and
ligand-dependent in vivo phosphorylation of RGS16 (result
not shown). This also indicates that the kinases responsible
for RGS16 phosphorylation do not belong to the MAPK
family. Furthermore, treatment of HEK293T cells expressing
the various RGS16 mutants with cycloheximide (for up to
8 h) did not indicate any change in stability of these proteins
compared to wild-type RGS16 (result not shown).
The phosphorylation of another mammalian RGS member,
GAIP, results in the acceleration of its GAP activity and
autophagy in human colon cancer HT-29 cells [13]. Serine
151 on GAIP, which is phosphorylated by the MAPK
ERK1/2, is located in the inter-helical region of helix 5 and
6, and is believed to be part of the binding region with GK [3].
In our present study, the RGS16 serine residues that are phos-
phorylated are located either in the extreme N-terminus of the
RGS box (S53) or outside of it (S194). We had previously
shown that the core domain of RGS16, in which both of these
two phosphorylation sites were deleted, still retains its binding
and GAP activity towards G proteins [23]. Consistent with
this conjecture, our experiments with the alanine mutants at
serine 53 and serine 194 of RGS16 (S53A, S194A, and S53A/
S194A) indicated no e¡ect on G-protein binding (result not
shown) or disruption of RGS GAP activity (Figs. 3 and 4).
Interestingly, double-glutamate mutant (S53E/S194E) sig-
ni¢cantly reduced RGS GAP activity, although it can still
bind to the G protein (Figs. 3 and 4, and result not shown).
Furthermore, determination of the soluble structures of RGS4
by nuclear magnetic resonance (NMR) has revealed signi¢-
cant di¡erences in both the N- and C-terminal regions of
the free RGS4 NMR structure with the RGS4-Gi1K X-ray
structure [24,25]. This suggests that in order to serve as an
e⁄cient GAP, RGS proteins in the presence of the GK sub-
unit, must undergo substantial conformational changes in-
volving both the N- and C-terminal regions to form an opti-
mal structure for binding to and stabilizing the transition state
of the GK subunit. Thus, the introduction of two negatively
charged phosphate groups on the N- and C-terminal regions
might interfere with the conformational changes, and possibly
result in a reduced GAP ability as seen in the double-gluta-
mate mutant of RGS16. As serine 194 is constitutively phos-
phorylated in mammalian HEK293T cells, expressing the sin-
gle-glutamate mutant of serine 53 should therefore give a
similar e¡ect as the double-glutamate mutant (S53E/S194E)
(Fig. 1). Hence, it is not surprising that in mammalian cells,
the S53E mutant also has a reduced capacity to inhibit epi-
nephrine-stimulated ERK2 activation. However, the S194E
mutant, which mimics the constitutively phosphorylated
wild-type RGS16, can inhibit ERK2 activation by epinephrine
(Fig. 4). These observations suggest that phosphorylation of
RGS16 on di¡erent sites can di¡erentially modulate its GAP
activity.
The recent observation that 14-3-3, a sca¡olding protein,
can directly interact with RGS3 and RGS7 [26], strongly sug-
gests that RGS proteins may have a more diverse role than
previously thought. The binding of RGS3 and RGS7 with 14-
3-3 is dependent on the phosphorylation of a conserved serine
located in the GK-interacting portion of the RGS domain,
and therefore also inhibited the RGS GAP activity [26]. De-
spite the presence of the conserved serine residue (S166) in
RGS16, we did not observe any phosphorylation of this res-
idue either constitutively or upon epinephrine stimulation. It
is likely that the phosphorylation event is tightly regulated
and speci¢c to certain stimuli as well as to distinct RGS mem-
bers, as in the case of the epinephrine-stimulated phosphory-
lation of RGS16. The ability of RGS proteins to interact with
molecules in addition to GK subunits was shown for the p115
RhoGEF [8], which interacts not only with G12K and Gi3K
subunits, but also with a guanine nucleotide exchange factor
for Rho, a member of the small G-protein family. Recently,
RGS12 is shown to interact with N-type calcium channels
through its PTB domain in a tyrosine-kinase-dependent man-
ner upon stimulation by Q-aminobutyric acid [27], which acts
via a GPCR. These ¢ndings further extend the role of RGS
proteins beyond acting as GAPs for GK subunits. Therefore,
it is conceivable that phosphorylation of RGS16 on serine 53
may generate a docking site for interaction with as-yet-iden-
ti¢ed molecules other than the G proteins, as in the case of
RGS3 and RGS7 interactions with 14-3-3 [26], or RGS12 with
N-type calcium channel [27]. This interaction with novel mol-
ecules may potentially inhibit the GAP function of RGS pro-
tein.
In summary, we have clearly shown that RGS16 is a phos-
phoprotein that can be phosphorylated on multiple serine
sites. Phosphorylation of RGS16 upon stimulation of the
K2A adrenergic receptor by epinephrine signi¢cantly reduced
its GAP function and consequently its attenuation of the
MAPK pathway. This is the ¢rst report of RGS phosphory-
lation and functional downregulation via a GPCR. It will be
interesting to explore whether such a phenomenon extends to
other RGS proteins.
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